We build a world-class pipeline by proprietary discovery platforms. Our innovation engine has been validated by clinical assets and global partnerships
H3 Antibody Technology
SynTracer® High Throughput
Endocytosis Platform
FlexiBody®
Bifunctional Platform
Biosion has developed a proprietary, state-of-the-art platform called H3 Antibody Technology that enables discovery of multiple therapeutic candidates with superior properties
Validated by clinical assets and global partnerships